News

Exothera S.A., a CDMO specialized in the development and manufacture of viral vectors for vaccines and gene therapies, received Good Manufacturing Practices (GMP) certification from the Federal Agency for Medicines and Health Products (FAMHP) for its facilities in Jumet,...

Wockhardt, located in India, and a Serum Institute of India affiliate have agreed to develop a new fill-finish production facility in Wrexham, North Wales (PDF). Financial information, as well as data on the initiation of the project, the size...

BioNTech and CureVac, two German mRNA companies, have agreed to offer Germany with vaccines for future medical catastrophes for the next many years. Reuters reported that Germany would pay up to 2.86 billion euros ($3.14 billion) to tie in...

Hundreds of businesses have announced a suspension or withdrawal of operations in Russia since its invasion of Ukraine. Some of the most recent companies to join the increasing list were Eli Lilly, Novartis, and AbbVie. Eli Lilly has halted the sale...

Only about half of women infected with ovarian cancer survive five years after diagnosis. AstraZeneca is partnering with a group of doctors and a network of patient advocacy groups to try to reverse this grim figure. The pharma behemoth...

After the US Food and Drug Administration postponed essential steps toward legalising COVID-19 vaccinations for children under the age of five by a month, many parents are more eager and enthused than ever. People are driving in from multiple states...

Thanks to a deal reached by NHS England, a targeted new medicine for a rare and severe form of lung cancer will be accessible to qualified patients within weeks. Mobocertinib, the only precision medicine accessible to patients with a...